38099144|t|Doxorubicin impairs cognitive function by upregulating AMPAR and NMDAR subunit expression and increasing neuroinflammation, oxidative stress, and apoptosis in the brain.
38099144|a|Introduction: The anticancer drug doxorubicin (DOX) is used for various malignancies. However, it also causes cognitive impairment in cancer survivors. In order to determine the mechanisms underlying the acute effects of DOX, we assessed the mRNA and protein expression of glutamate receptors and proteins involved in cognitive function and apoptosis. Methods: Fear-conditioning memory tests were performed in rats after a single intraperitoneal injection of DOX (25 mg/kg) to evaluate short-term memory function. Rat brain samples were collected, and GluA1 mRNA and protein expression; NR2A and NR2B mRNA expression; and COX-2, NF-kB, TNF-alpha, and MDA, Bax, and caspase-3 levels were assessed via reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assays. Results: We observed a decreased number of entries in Y-maze, decreased exploration time to the novel object in the novel object recognition (NOR), and decreased freezing time in the fear-conditioning memory tests in DOX-treated rats relative to those in control rats, demonstrating cognitive impairment. GluA1, NR2B, and NR2A expression and MDA, NF-kappaB, Bax, COX-2, TNF-alpha, and caspase-3 levels in the brain were significantly elevated in DOX-treated rats. Conclusion: DOX induced cognitive impairment in the rats via neuronal toxicity by upregulating AMPAR and NMDAR expression and increasing neuroinflammation, oxidative stress, and apoptosis in the brain.
38099144	0	11	Doxorubicin	Chemical	MESH:D004317
38099144	105	122	neuroinflammation	Disease	MESH:D000090862
38099144	204	215	doxorubicin	Chemical	MESH:D004317
38099144	217	220	DOX	Chemical	MESH:D004317
38099144	242	254	malignancies	Disease	MESH:D009369
38099144	280	300	cognitive impairment	Disease	MESH:D003072
38099144	304	310	cancer	Disease	MESH:D009369
38099144	391	394	DOX	Chemical	MESH:D004317
38099144	580	584	rats	Species	10116
38099144	629	632	DOX	Chemical	MESH:D004317
38099144	684	687	Rat	Species	10116
38099144	722	727	GluA1	Gene	50592
38099144	757	761	NR2A	Gene	24409
38099144	766	770	NR2B	Gene	24410
38099144	792	797	COX-2	Gene	26198
38099144	799	804	NF-kB	Gene	309165
38099144	806	815	TNF-alpha	Gene	24835
38099144	826	829	Bax	Gene	24887
38099144	835	844	caspase-3	Gene	25402
38099144	1175	1178	DOX	Chemical	MESH:D004317
38099144	1187	1191	rats	Species	10116
38099144	1221	1225	rats	Species	10116
38099144	1241	1261	cognitive impairment	Disease	MESH:D003072
38099144	1263	1268	GluA1	Gene	50592
38099144	1270	1274	NR2B	Gene	24410
38099144	1280	1284	NR2A	Gene	24409
38099144	1300	1303	MDA	Chemical	MESH:D015104
38099144	1316	1319	Bax	Gene	24887
38099144	1321	1326	COX-2	Gene	26198
38099144	1328	1337	TNF-alpha	Gene	24835
38099144	1343	1352	caspase-3	Gene	25402
38099144	1404	1407	DOX	Chemical	MESH:D004317
38099144	1416	1420	rats	Species	10116
38099144	1434	1437	DOX	Chemical	MESH:D004317
38099144	1446	1466	cognitive impairment	Disease	MESH:D003072
38099144	1474	1478	rats	Species	10116
38099144	1483	1500	neuronal toxicity	Disease	MESH:D009410
38099144	1559	1576	neuroinflammation	Disease	MESH:D000090862
38099144	Positive_Correlation	MESH:D004317	MESH:D015104
38099144	Association	MESH:D004317	MESH:D009410
38099144	Positive_Correlation	MESH:D004317	24410
38099144	Positive_Correlation	MESH:D004317	MESH:D003072
38099144	Positive_Correlation	MESH:D004317	24887
38099144	Positive_Correlation	MESH:D004317	26198
38099144	Positive_Correlation	MESH:D004317	25402
38099144	Positive_Correlation	MESH:D004317	24835
38099144	Positive_Correlation	MESH:D004317	24409
38099144	Positive_Correlation	MESH:D004317	MESH:D000090862
38099144	Positive_Correlation	MESH:D004317	50592
38099144	Negative_Correlation	MESH:D004317	MESH:D009369

